4
Changes in Ownership
Immunome Inc. Filed Acc 0001997584-26-000004
Chief Medical Officer sold 55,000 shares at an average $22.62 ($1,244,331)
- Chief Medical Officer acquired 55,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Lechleider Robert · Chief Medical Officer
Table I: Non-derivative
4 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +55,000 | $8.73 | $480,150 | 70,805 | D |
| 2026-07-02 | Sale : show line 2 in the form 10b5-1 | −22,714 | $21.95 | $498,572 | 48,091 | D |
| 2026-07-02 | Sale : show line 3 in the form 10b5-1 | −16,214 | $22.76 | $369,031 | 31,877 | D |
| 2026-07-02 | Sale : show line 4 in the form 10b5-1 | −16,072 | $23.44 | $376,728 | 15,805 | D |
| Open-market sales · 55,000 sh · avg $22.62 · $1,244,331 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-02 | Exercise or conversion : show line 5 in the form 10b5-1 Employee Stock Option (right to buy) | −55,000 | 290,000 | D |
Loading xslF345X06/form4-07072026_090711.xml…